(Redirected from (-)-2β-Carbomethoxy-3β-(4-iodophenyl)tropane)
Brief summary - RTI-55
RTI(-4229)-55, also called RTI-55 or iometopane, is a phenyltropane-based psychostimulant used in scientific research and in some medical applications. This drug was first cited in 1991. RTI-55 is a non-selective dopamine reuptake inhibitor derived from methylecgonidine. However, more selective analogs are derived by conversion to pyrrolidinoamido RTI-229, for instance. Due to the large bulbous nature of the weakly electron withdrawing iodo halogen atom, RTI-55 is the most strongly serotonergic of the simple para-substituted troparil based analogs. In rodents RTI-55 actually caused death at a dosage of 100 mg/kg, whereas RTI-51 and RTI-31 did not. Another notable observation is the strong propensity of RTI-55 to cause locomotor activity enhancements, although in an earlier study, RTI-51.
RTI-55 - AI prompts and tools
- As a Professor: - Act as a professor, expand and write a detailed article on RTI-55.
- Encyclopedia Entry: - Generate a comprehensive encyclopedia article on the topic of RTI-55.
- Subject Matter Expertise: - Expand and refine the content provided to create a professional article on RTI-55 with references.
Note:Feel free to use AI tools to expand this topic using the text on the page followed by the prompt.
|stub. Help WikiMD grow by registering to expand it.|